Advin Biotech Inc

Advin Biotech Inc manufactures FDA-cleared and CLIA-waived drugs of abuse testing products for clinical, workplace, and home use. The company specializes in innovative point-of-care immunoassay formats including urine drug test cups, dipcard assays, and oral fluid tests. Key product innovations include the iSplit Cup (with removable specimen vessel for pristine retention and confirmation testing), POCiT Cup (integrated specimen tube for liquid handler automation), and proprietary 1-second dipcard technology for batch testing efficiency. Product portfolio covers all standard drugs of abuse assays plus specialized tests for EtG, Tramadol, Fentanyl, Ketamine, and the first US FDA-cleared 6AM metabolite test. All tests are customizable for cutoff levels and available for private labeling and co-branding partnerships. The company operates an FDA-registered IVD manufacturing facility in the U.S. with in-house proprietary automated manufacturing processes, ensuring batch-to-batch consistency. Advin Biotech also manufactures COVID-19 antigen tests (EUA-authorized for home use) and oral fluid specimen collection products (SalivaTracer). The company provides on-demand technical support through in-house toxicologists and offers tailored pricing and customization services. Manufacturing and R&D capabilities are conducted domestically with emphasis on quality, speed, and cost efficiency.